NCT05557045
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05557045
Title A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jazz Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
SCRI HealthOne RECRUITING Denver Colorado 80218 United States Details
Florida Cancer Specialists - Lake Nona RECRUITING Orlando Florida 32827 United States Details
Florida Cancer Specialists - Sarasota RECRUITING Sarasota Florida 34232 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Oklahoma University RECRUITING Oklahoma City Oklahoma 73104 United States Details
Sidney Kimmel Cancer Center RECRUITING Philadelphia Pennsylvania 19107 United States Details
Tennessee Oncology - Nashville RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology- Central South RECRUITING Austin Texas 78731 United States Details
Texas Oncology- Gulf Coast RECRUITING The Woodlands Texas 77380 United States Details
Virginica Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field